Literature DB >> 31797341

Extended Oral Antibiotics and Infection Prophylaxis after a Primary or Revision Total Knee Arthroplasty.

Cierra S Hong1, Collin S Black1, Sean P Ryan2, Thorsten M Seyler2.   

Abstract

One of the most common reasons for failure of primary total knee arthroplasty and need for revision surgery is periprosthetic infection. Antibiotics are one of the mainstays of treatment to address prosthetic joint infections, but the route of administration and timing of delivery to optimize patient outcomes are debated. This article reviews the use and attributes of commonly used oral antibiotics, especially extended or long-term utilization, as prophylaxis and treatment for prosthetic joint infections in a primary or revision total knee arthroplasty, which include debridement, antibiotics, and implant retention, one-stage and two-stage exchange arthroplasty. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Year:  2019        PMID: 31797341     DOI: 10.1055/s-0039-3400755

Source DB:  PubMed          Journal:  J Knee Surg        ISSN: 1538-8506            Impact factor:   2.757


  4 in total

1.  Cefadroxil-Induced Clostridium difficile Infection Following Total Knee Arthroplasty.

Authors:  Nathan Angerett; Christopher Ferguson; Michael Kahan; Devin Fitz; Richard Hallock
Journal:  Arthroplast Today       Date:  2022-10-12

2.  Two-Stage Total Knee Arthroplasty Revision With Extended Antibiotic Spacer Use.

Authors:  Clayton R Welsh; Patricia A Baumann
Journal:  Cureus       Date:  2021-05-05

Review 3.  Clinical and radiological outcomes in three-dimensional printing assisted revision total hip and knee arthroplasty: a systematic review.

Authors:  Rui Zhang; Jiajun Lin; Fenyong Chen; Wenge Liu; Min Chen
Journal:  J Orthop Surg Res       Date:  2021-08-13       Impact factor: 2.359

Review 4.  Connections between Orthopedic Conditions and Oxidative Stress: Current Perspective and the Possible Relevance of Other Factors, Such as Metabolic Implications, Antibiotic Resistance, and COVID-19.

Authors:  Bogdan Huzum; Alexandrina Stefania Curpan; Bogdan Puha; Dragomir Nicolae Serban; Bogdan Veliceasa; Riana Maria Necoara; Ovidiu Alexa; Ionela Lacramioara Serban
Journal:  Medicina (Kaunas)       Date:  2022-03-17       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.